| Document |
Document Title |
|
WO/2022/013027A1 |
The invention relates to noble metal-oxo clusters represented by the formula [Ms(R2XO2)z(OR')xOyX'q] or solvates thereof, corresponding supported noble metal-oxo clusters, and processes for their preparation, as well as corresponding met...
|
|
WO/2022/008656A1 |
The present invention relates to an optically pure (+) or (-) enantiomer of a ruthenium complex having formula (I) as well as the preparation method of said enantiomer, and uses thereof as catalyst, in particular in asymmetric olefin met...
|
|
WO/2022/008679A1 |
The present invention relates to a ruthenium complex having the following formula (I) as well as the preparation method of said enantiomer, and uses thereof as catalyst, in particular in asymmetric olefin metathesis.
|
|
WO/2022/008946A1 |
The present invention relates to an optically pure (+) or (–) enantiomer of a ruthenium complex having the following formula (I) as well as the preparation method of said enantiomer, and uses thereof as catalyst, in particular in asymm...
|
|
WO/2022/009695A1 |
The present invention provides: an alkoxide compound represented by general formula (1); a thin film-forming material containing said compound; and a method for manufacturing a thin film. (In the formula, R1 and R2 each independently rep...
|
|
WO/2021/258875A1 |
The present invention relates to a metal iridium complex and use thereof. The metal iridium complex has a structure as shown in Formula (I). The compound provided by the present invention has the advantages of low sublimation temperature...
|
|
WO/2021/259505A1 |
The invention relates to a noble metal complex comprising diolefin and C6-C18 monocarboxylate ligands of the type [LPd[O(CO)R1]X]n, [LRh[O(CO)R1]]m or [LIr[O(CO)R1]]m, in which L represents a compound acting as a diolefin ligand, wherein...
|
|
WO/2021/253774A1 |
A preparation method of a radiophotoluminescent material, comprising the following steps: mixing a soluble metal salt, a ligand and a solvent to obtain a mixed solution, and synthesizing a metal organic framework crystal from the mixed s...
|
|
WO/2021/254026A1 |
A tetradentate metal complex having a structure of formula (I) and the use thereof. The tetradentate metal complex has the advantages of a good optical, electrical and thermal stability, a high luminous efficiency, a long lifespan, a hig...
|
|
WO/2021/254811A1 |
The present invention relates to a process for producing specific α,β-unsaturated carboxylates.
|
|
WO/2021/251750A1 |
The present invention relates to a modified μ-oxo centered-multinuclear metal complex compound, in which Si and/or Al is bound via a ligand containing an organic functional group having a non-covalent electron pair capable of binding to...
|
|
WO/2021/249514A1 |
The present invention relates to the technical field of organic light-emitting materials, and provides a tetradentate cyclometalated platinum (II) complex based on an oxygen atom linkage and containing phenyl acridine and an application ...
|
|
WO/2021/249507A1 |
The present invention relates to the technical field of organic light-emitting materials, and provides a quadridentate ring metal platinum (II) complex based on carboxyl coordination and comprising pyridyl acridine and the use thereof; t...
|
|
WO/2021/245148A1 |
Complex containing betaine, transition metal and sulfate in a ratio of 1:1:1, the transition metal being coordinated with two oxygen atoms from the betaine.
|
|
WO/2021/244222A1 |
The present invention relates to a metal complex and use thereof. The metal complex has a general formula of Ir(La)(Lb)(Lc), and comprises a structure represented by formula (1) as the ligand La. The metal complex provided by the present...
|
|
WO/2021/247531A1 |
The present disclosure relates to metal di-amino acid chelates and metal tri-amino acid chelates.
|
|
WO/2021/240357A1 |
Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure dev...
|
|
WO/2021/240355A1 |
Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is al...
|
|
WO/2021/238623A1 |
The present invention relates to an ONCN quadridentate ligand-containing platinum complex and an application thereof in an organic light-emitting diode. The platinum complex is a compound having a structure of chemical formula (I). The c...
|
|
WO/2021/236764A1 |
The present disclosure provides for a rhodium-catalyzed oxidative arene alkenylation from arenes and styrenes to prepare stilbene and stilbene derivatives. For example, the present disclosure provides for method of making arenes or subst...
|
|
WO/2021/233147A1 |
The present invention relates to the preparation and use of a novel tetradentate platinum(II) complex, and belongs to the field of OLED organic electroluminescent materials. The complex of the present invention has an NCNC chelating coor...
|
|
WO/2021/223634A1 |
The present invention relates to a specific combination of a host compound and a multiple-deuterated guest compound, and an optoelectronic device comprising the composition. The composition of the present invention has a good thermal sta...
|
|
WO/2021/221237A1 |
The present invention relates to a ferrocene-based compound showing high selectivity towards sulfide ions, wherein the ferrocene-based compound is obtained by reacting a ferrocene starting material with one or more organic compounds sele...
|
|
WO/2021/222018A1 |
Compositions may comprise symmetrical and asymmetrical pyridine-containing transition metal-complexes having appended group (13) Lewis acids positioned on the pyridine-containing ligands of the transition metal-complex such that the grou...
|
|
WO/2020/212296A9 |
The present invention relates to metal complexes and electronic devices, in particular organic electroluminescent devices, containing said metal complexes.
|
|
WO/2021/218892A1 |
The present invention relates to a divalent platinum anticancer compound having a novel structure and a use thereof. The compound shown in formula (I) of the present invention and a pharmaceutically acceptable salt or stereoisomer thereo...
|
|
WO/2021/215792A1 |
The present application provides a mononuclear transition metal complex, a photocatalyst for carbon dioxide reduction including same, and a method for reducing carbon dioxide to formic acid, the method comprising using the photocatalyst ...
|
|
WO/2021/215210A1 |
The present invention provides a metal complex which is useful for the production of a light emitting element that has excellent luminous efficiency. A metal complex which is represented by formula (1). (In the formula, M represents a ...
|
|
WO/2021/205958A1 |
The present invention provides an amidinate compound represented by general formula (1) or a dimer compound thereof, and a method for producing a thin film using said compound as a raw material. (In the formula, R1 and R2 each independen...
|
|
WO/2021/199507A1 |
The purpose of the present invention is to provide: a compound which has a metal uptake ability and which, when formed into an iron complex, is suitable as an iron supply material for cultivation using foliar spraying and hydroponics; a ...
|
|
WO/2021/192795A1 |
Provided is a color conversion composition having excellent chromaticity stability, the color conversion composition containing the following components (A), (B), and (C). Component (A): a light-emitting material; component (B): a binder...
|
|
WO/2021/190076A1 |
Anti-tumor compounds 1 and 2 capable of overcoming cisplatin resistance, preparation therefor, and applications thereof. The compounds have activities of inhibiting protein kinase 2 (casein kinase, CK2) and so can inhibit DNA damage repa...
|
|
WO/2021/186087A1 |
The invention relates to a process for preparing trimethylplatinum(IV) iodide and also to trimethylplatinum(IV) iodide obtainable by this process and to the use thereof as reactant for the preparation of platinum(IV) compounds, as precat...
|
|
WO/2021/179792A1 |
Disclosed in the present invention are a gene interference vector- and iron nanoparticle-based composition for killing cancer cells, and the use thereof. The composition comprises a gene interference vector and iron nanoparticles, wherei...
|
|
WO/2021/183669A1 |
Provided herein are methods of catalytic hydrosilylation, including triggerable methods, using metal-ligand complexes as catalysts, characterized by formula MLxDy; wherein: M is a metal; x is equal to the oxidation state of M; each D is ...
|
|
WO/2021/177748A1 |
The present specification relates to: a compound represented by chemical formula 1; an optical film-forming composition and an optical film, each comprising same; and a display device comprising the optical film.
|
|
WO/2021/177750A1 |
The present specification relates to a compound represented by chemical formula 1, a composition comprising same for forming an optical film, an optical film comprising the compound, and a display apparatus comprising the optical film.
|
|
WO/2021/177650A1 |
The present specification relates to: a compound represented by chemical formula 1; an optical film forming composition and an optical film which comprise same; and a display device comprising the optical film.
|
|
WO/2021/177368A1 |
[Problem] To provide a method for producing ammonia and hydrazine using an iron complex. [Solution] This method for producing ammonia and hydrazine from a nitrogen molecule in the presence of an iron catalyst, a reducing agent, and a pro...
|
|
WO/2021/172433A1 |
A problem addressed by the present invention is to provide a novel metal-organic framework with a dicarboxylic acid having a terphenyl skeleton as an organic ligand, and a gas storage method using the same. A metal-organic framework ob...
|
|
WO/2021/174035A1 |
In one aspect, transition metal complexes are described herein having composition and electronic structure for generating reactive labeling intermediates having lifetimes and diffusion radii advantageous for proximity-based labeling of v...
|
|
WO/2021/172842A1 |
Disclosed are a method for preparing a perovskite compound and a perovskite photoelectric device comprising same. A method for preparing a perovskite compound according to an embodiment of the present invention comprises the steps of: pr...
|
|
WO/2021/170001A1 |
The present invention relates to an oxaliplatin-flavonoid drug eutectic crystal, a preparation method therefor and use thereof. Specifically, disclosed is an oxaliplatin-flavonoid drug eutectic crystal. The eutectic crystal has excellent...
|
|
WO/2021/162115A1 |
This display device contains a wavelength converting material and a laminate that includes the gas barrier layer described below and a wavelength selective absorption layer, which contains a resin, a dye that contains at least one of fou...
|
|
WO/2021/161974A1 |
The present invention relates to an iridium complex compound represented by formula (1) (in formula (1), Ir represents an iridium atom, R5 to R14, R21, and R22 each independently represent a hydrogen atom, D, F, Cl, Br, I, or a substitue...
|
|
WO/2021/154931A1 |
Methods of polymer and/or oligomer depolymerization are described herein which, in some embodiments, enable facile polymer and/or oligomer decomposition under mild, non-energy intensive conditions. Briefly, a method of depolymerization c...
|
|
WO/2021/153640A1 |
The present invention pertains to an organic ruthenium compound raw material for chemical vapor deposition methods. The organic ruthenium compound, in which a trimethylenemethane ligand (L1) as well as 2 carbonyl ligands and a ligand X a...
|
|
WO/2021/153639A1 |
The present invention pertains to an organic ruthenium compound raw material for producing a ruthenium thin film or a ruthenium compound thin film by means of chemical vapor deposition. The organic ruthenium compound, in which a trimethy...
|
|
WO/2021/148702A1 |
The titanium(IV) and iron(III) MOF solid MUV-17 (TiFe2), has the general formula (1): [TiIVFeIII2(O)(L)2(X)3]S, where X is each equal or different selected from: O2-, OH-, H2O, F-, Cl-, Br-, I-, NO3-, ClO4-, BF4-, SCN-, OH-, CH3COO-, C5H...
|
|
WO/2021/148935A1 |
The present invention relates to a transition metal complex (Z) (described herein), which is stable and can be effectively used as a catalyst in various chemical transformations such as to prepare chemical intermediates, agrochemical com...
|
